<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Epidemiology of nontuberculous mycobacterial infections
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Epidemiology of nontuberculous mycobacterial infections
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Epidemiology of nontuberculous mycobacterial infections
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            David E Griffith, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            C Fordham von Reyn, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Allyson Bloom, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jun 23, 2021.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Mycobacteria other than
         <em>
          Mycobacterium tuberculosis
         </em>
         and
         <em>
          Mycobacterium leprae
         </em>
         are generally free-living organisms that are ubiquitous in the environment (
         <a class="graphic graphic_table graphicRef61936" href="/z/d/graphic/61936.html" rel="external">
          table 1
         </a>
         ). They have been recovered from surface water, tap water, soil, domestic and wild animals, milk, and food products [
         <a href="#rid1">
          1-4
         </a>
         ]. These organisms can also inhabit body surfaces or secretions without causing disease. Thus, occasional isolates of nontuberculous mycobacteria (NTM) were largely considered contaminants or colonizers until the second half of this century. However, as tuberculosis declined and modern microbiological methods were developed, the importance of NTM in human disease became increasingly evident.
        </p>
        <p>
         In broad terms, NTM cause four distinct clinical syndromes [
         <a href="#rid5">
          5,6
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Progressive pulmonary disease caused primarily (in the United States) by
         <em>
          Mycobacterium avium
         </em>
         complex (MAC),
         <em>
          M. abscessus
         </em>
         complex, and
         <em>
          M. kansasii
         </em>
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Superficial lymphadenitis, especially cervical lymphadenitis, in children caused mostly by MAC,
         <em>
          M. scrofulaceum
         </em>
         , and, in northern Europe,
         <em>
          M. malmoense
         </em>
         and
         <em>
          M. haemophilum
         </em>
         ; the most common cause in adults, however, is
         <em>
          M. tuberculosis
         </em>
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Disseminated disease in severely immunocompromised patients
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Skin and soft tissue infection usually as a consequence of direct inoculation
        </p>
        <p>
        </p>
        <p>
         The epidemiology of NTM will be reviewed here. An overview of NTM in HIV-negative and HIV-positive patients, as well as the pathogenesis, microbiology, diagnosis, and treatment of NTM infections are presented separately. Rapidly growing NTM infections in HIV-negative patients,
         <em>
          M. avium
         </em>
         complex infections in HIV-infected patients, and NTM infections in solid organ transplant candidates and recipients are also discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/5342.html" rel="external">
          "Overview of nontuberculous mycobacterial infections"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3705.html" rel="external">
          "Overview of nontuberculous mycobacteria (excluding MAC) in patients with HIV"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5345.html" rel="external">
          "Pathogenesis of nontuberculous mycobacterial infections"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5343.html" rel="external">
          "Microbiology of nontuberculous mycobacteria"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5346.html" rel="external">
          "Diagnosis of nontuberculous mycobacterial infections of the lungs"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5341.html" rel="external">
          "Treatment of
          <i>
           Mycobacterium avium
          </i>
          complex pulmonary infection in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5347.html" rel="external">
          "Rapidly growing mycobacterial infections: Mycobacteria abscessus, chelonae, and fortuitum"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3755.html" rel="external">
          "Mycobacterium avium complex (MAC) infections in persons with HIV"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1413.html" rel="external">
          "Nontuberculous mycobacterial infections in solid organ transplant candidates and recipients"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3913418534">
         <span class="h1">
          COMMON PATHOGENIC SPECIES
         </span>
         <span class="headingEndMark">
          —
         </span>
         The most common nontuberculous species causing human disease in the United States are the slowly growing species of the
         <em>
          M. avium
         </em>
         complex (MAC) and
         <em>
          M. kansasii
         </em>
         and the rapidly growing
         <em>
          M. abscessus
         </em>
         complex. Less common human pathogens include the slowly growing species
         <em>
          M. marinum
         </em>
         ,
         <em>
          M. xenopi
         </em>
         ,
         <em>
          M. simiae
         </em>
         ,
         <em>
          M. malmoense
         </em>
         , and
         <em>
          M. ulcerans
         </em>
         , and the rapidly growing species
         <em>
          M. abscessus
         </em>
         subspecies
         <em>
          massiliense
         </em>
         and
         <em>
          bolletii
         </em>
         ,
         <em>
          M. fortuitum
         </em>
         , and
         <em>
          M. chelonae
         </em>
         .
        </p>
        <p>
         Among children, the predominant NTM disease in children is cervical lymphadenitis due to MAC and
         <em>
          M. scrofulaceum
         </em>
         and cutaneous disease due to
         <em>
          M. marinum
         </em>
         and
         <em>
          M. ulcerans
         </em>
         [
         <a href="#rid7">
          7
         </a>
         ]. Rare cases of disseminated disease have been reported in children [
         <a href="#rid8">
          8,9
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3547934745">
         <span class="h1">
          FREQUENCY OF DISEASE
         </span>
        </p>
        <p class="headingAnchor" id="H3062811492">
         <span class="h2">
          Challenges in estimating incidence/prevalence
         </span>
         <span class="headingEndMark">
          —
         </span>
         The precise frequency of disease due to the different species of NTM is unknown. Determining the incidence and prevalence of NTM lung disease is difficult because disease reporting is not mandatory in the United States and many other countries. Additionally, mere isolation of NTM does not necessarily indicate disease, and studies that use the frequency of NTM isolates as a surrogate for disease prevalence may overestimate it.
        </p>
        <p>
         The best option for evaluating NTM lung disease epidemiology may be use of diagnostic codes in databases from large health care delivery systems, managed care providers, and health care insurers. However, there are potential limitations with this approach that can result in both underdiagnosis (lack of disease recognition by the clinician) and overdiagnosis (inappropriate diagnosis for patients who do not meet diagnostic criteria), since the accuracy of diagnostic codes depends on the clinical acumen of the clinician assigning them.
        </p>
        <p>
         Clinical diagnosis of NTM lung disease is based on three criteria: symptoms, microbiology, and radiographic findings. Although some studies suggest that using the microbiologic criterion alone may be an acceptable proxy for disease for epidemiologic purposes in specific populations, it is unclear whether these are generalizable to larger and more diverse patient populations [
         <a href="#rid10">
          10,11
         </a>
         ]. As an example, in a study of 367 patients on tumor necrosis factor alpha inhibitor therapy for rheumatoid arthritis, who had either a culture positive for NTM or had a diagnostic code for NTM, meeting microbiologic criteria (ie, one positive culture from a bronchoscopic specimen or two sputum cultures positive for the same species) a positive predictive value for NTM lung disease according to full criteria of 78 to 100 percent, depending on the center [
         <a href="#rid11">
          11
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1013190692">
         <span class="h2">
          Increasing burden of disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         Despite methodologic differences, studies show a remarkably consistent trend of increasing NTM disease (particularly lung disease) prevalence, especially in older and female patients. Reasons for this observation are not immediately clear. Some increase may be due to better awareness of NTM lung disease, better diagnostic tools, and changing coding practices for NTM lung disease. It is also possible there is a true increase in NTM lung disease prevalence due to more extensive environmental NTM exposure or host susceptibility factors, such as increased incidence of bronchiectasis and/or chronic obstructive pulmonary disease (COPD) or use of immunosuppressive agents, including inhaled corticosteroids [
         <a href="#rid12">
          12
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H5482315">
         <span class="h3">
          Global trends
         </span>
         <span class="headingEndMark">
          —
         </span>
         Based upon the available data, the burden of NTM appears to be increasing worldwide. One comprehensive review of available information about global NTM disease prevalence emphasized the heterogeneity of isolates and disease burden worldwide but concluded that available population-based data suggested that NTM pulmonary disease was increasing in North America, Europe, Asia, and Australia [
         <a href="#rid13">
          13
         </a>
         ].
        </p>
        <p>
         NTM lung disease is especially prevalent in parts of Asia. One study from Japan analyzed data from NTM lung disease health insurance claims between 2009 and 2014 [
         <a href="#rid14">
          14
         </a>
         ]. In this study, NTM lung disease was identified by at least one claim associated with an NTM diagnostic code and at least one claim for combinations of antimycobacterial medications. The prevalence in 2011 was 29 per 100,000 persons and was higher among females than males in most age groups. The most common comorbidities were bronchiectasis for women and COPD for men. Another study using a different method estimated a prevalence of 25 per 100,000 persons in Japan in 2019 [
         <a href="#rid15">
          15
         </a>
         ]. In South Korea, a report found that prevalence of NTM lung disease between 2007 and 2016 increased from 6.7 cases to 39.6 cases per 100,000 persons [
         <a href="#rid16">
          16
         </a>
         ]. Overall prevalence for the study was higher in older adults and in females.
        </p>
        <p>
         In Ontario, Canada, prevalence of patients meeting ATS microbiologic criteria for NTM lung disease also increased 10 percent per year from 2003 to 2008 [
         <a href="#rid17">
          17
         </a>
         ]. In a study of pulmonary NTM cases in Queensland, Australia, where NTM disease is a notifiable condition, the incidence of cases rose from 2.2 to 3.2 per 100,000 population between 1999 and 2005 [
         <a href="#rid18">
          18
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1788234300">
         <span class="h3">
          Trends in the United States
         </span>
         <span class="headingEndMark">
          —
         </span>
         Trends in NTM disease in the United States are similar to those worldwide, with increasing prevalence, particularly among females in older age groups.
        </p>
        <p>
         One study reviewed annual medical claims with diagnostic codes for NTM disease within a national managed care database that represented a geographically diverse population of approximately 27,000,000 members [
         <a href="#rid19">
          19
         </a>
         ]. A case of NTM lung disease was defined as having at least two medical claims with an NTM diagnostic code dated at least 30 days apart. From 2008 to 2015, the annual incidence of NTM lung disease increased from 3.1 to 4.7 per 100,000 person-years, and the annual prevalence increased from 6.8 to 11.7 per 100,000 persons. The average annual increases in incidence and prevalence were 5.2 and 7.5 percent, respectively. For women, the annual incidence increased from 4.2 to 6.7 per 100,000 person-years, and the annual prevalence increased from 9.6 to 16.8 per 100,000 persons. For individuals age 65 years or older, the annual incidence increased from 12.7 to 18.4 per 100,000 person-years, and the annual prevalence increased from 30.3 to 47.5 per 100,000 persons. The incidence and prevalence of NTM lung disease increased in most states as well as at the national level.
        </p>
        <p>
         Earlier studies had also suggested a trend towards increased incidence and prevalence over the prior two decades [
         <a href="#rid20">
          20-22
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3299870432">
         <span class="h3">
          Patients with cystic fibrosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         NTM strains are commonly isolated from sputum in patients with cystic fibrosis and may be clinically significant. In a study of more than 16,000 persons with cystic fibrosis, 20 percent had a pathogenic NTM species isolated at least once over a five-year period [
         <a href="#rid23">
          23
         </a>
         ]. Most (61 percent) had MAC and 39 percent had
         <em>
          M. abscessus
         </em>
         complex isolated. Patients with either MAC or
         <em>
          M. abscessus
         </em>
         complex were significantly more likely to have been diagnosed with cystic fibrosis at an older age, have a lower body mass index, and have fewer years of chronic macrolide therapy. The incidence appeared to increase over time. (See
         <a class="medical medical_review" href="/z/d/html/6371.html" rel="external">
          "Cystic fibrosis: Antibiotic therapy for chronic pulmonary infection", section on 'Nontuberculous mycobacteria'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H22990476">
         <span class="h1">
          HOST SUSCEPTIBILITY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Many risk factors for NTM diseases are specific to the clinical syndrome or the species. However, a number of inherited and acquired defects in the host immune response, particularly those that affect the Th1 cell and macrophage pathway, have been associated with increased susceptibility to NTM infections in general. Many of these host immune defects are associated especially with disseminated infection. (See
         <a class="medical medical_review" href="/z/d/html/5345.html" rel="external">
          "Pathogenesis of nontuberculous mycobacterial infections", section on 'Mycobacterium avium complex'
         </a>
         .)
        </p>
        <p>
         These defects are discussed in further detail elsewhere and include the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Interferon gamma receptor deficiencies (see
         <a class="medical medical_review" href="/z/d/html/3958.html" rel="external">
          "Mendelian susceptibility to mycobacterial diseases: Specific defects", section on 'IFN-gamma receptor deficiencies'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Signal transducer and activator of transcription 1 (STAT1) deficiency (see
         <a class="medical medical_review" href="/z/d/html/3958.html" rel="external">
          "Mendelian susceptibility to mycobacterial diseases: Specific defects", section on 'STAT1 defects'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Auto-antibodies to interferon gamma (see
         <a class="medical medical_review" href="/z/d/html/89801.html" rel="external">
          "Mendelian susceptibility to mycobacterial diseases: An overview", section on 'Differential diagnosis'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         CD4 lymphopenia due to HIV or other causes (see
         <a class="medical medical_review" href="/z/d/html/3755.html" rel="external">
          "Mycobacterium avium complex (MAC) infections in persons with HIV"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3705.html" rel="external">
          "Overview of nontuberculous mycobacteria (excluding MAC) in patients with HIV"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3917.html" rel="external">
          "Idiopathic CD4+ lymphocytopenia", section on 'Mycobacteria'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Use of TNF-alpha inhibitors, particularly
         <a class="drug drug_general" data-topicid="8984" href="/z/d/drug information/8984.html" rel="external">
          infliximab
         </a>
         and
         <a class="drug drug_general" data-topicid="8583" href="/z/d/drug information/8583.html" rel="external">
          adalimumab
         </a>
         (see
         <a class="medical medical_review" href="/z/d/html/1411.html" rel="external">
          "Risk of mycobacterial infection associated with biologic agents and JAK inhibitors", section on 'Nontuberculous mycobacterial disease'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H720686201">
         <span class="h1">
          HOST PROTECTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Few patient characteristics that are protective of infection with NTM have been described. Epidemiologic studies from Sweden and Finland have suggested that childhood immunization with Bacillus Calmette-Guerin (BCG) vaccine is associated with a reduced risk of childhood cervical lymphadenitis due to NTM [
         <a href="#rid24">
          24,25
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h1">
          MYCOBACTERIUM AVIUM COMPLEX
         </span>
         <span class="headingEndMark">
          —
         </span>
         The members of the
         <em>
          M. avium
         </em>
         complex (MAC) are ubiquitous, free-living organisms readily recovered from natural reservoirs including soil and water, domestic and wild animals, and foodstuffs [
         <a href="#rid26">
          26
         </a>
         ]. Environmental MAC isolates and clinical isolates belong to different serovars [
         <a href="#rid27">
          27
         </a>
         ]. However, mycobacteria can become aerosolized from aqueous sources, and the more easily aerosolized strains are often phenotypically the same as those that cause pulmonary infections [
         <a href="#rid28">
          28,29
         </a>
         ]. Isolates similar or identical to clinical isolates have also been recovered from naturally occurring surface water, hot tubs, and piped hot water systems [
         <a href="#rid27">
          27,30-32
         </a>
         ]. Prolonged exposure to soil has also been identified as a risk factor for MAC infection in the United States [
         <a href="#rid33">
          33
         </a>
         ]. Studies using gene sequence analyses have demonstrated that NTM are enriched to high levels in many showerhead biofilms, supporting previous theories that showers may represent another potential source of MAC infection in humans [
         <a href="#rid34">
          34,35
         </a>
         ].
        </p>
        <p>
         Unlike
         <em>
          M. tuberculosis
         </em>
         , there are no convincing data demonstrating human-to-human transmission of infection. Thus, the concept prevails that these organisms are acquired from the environment. Furthermore, environmental exposure to these organisms must be common because data from several countries showed that a substantial fraction of children have delayed cutaneous hypersensitivity responses to MAC antigens, a fraction that increases with age [
         <a href="#rid36">
          36-38
         </a>
         ].
        </p>
        <p>
         A smaller survey of skin test reactivity to
         <em>
          M. intracellulare
         </em>
         antigen was reported from the National Health and Nutrition Examination Surveys (NHANES) comparing results from 1971 to 1972 with 1999 to 2000 [
         <a href="#rid39">
          39
         </a>
         ]. Between these two time periods, the prevalence of
         <em>
          M. intracellulare
         </em>
         sensitization increased from 11.2 to 16.6 percent. The authors concluded that from 1999 to 2000, an estimated one in six persons in the US demonstrated
         <em>
          M. intracellulare
         </em>
         sensitization, up from one in nine persons from 1971 to 1972. They felt that the observed rising prevalence of sensitization was consistent with observed increases in rates of pulmonary NTM isolates in the United States (US) [
         <a href="#rid40">
          40
         </a>
         ]. (See
         <a class="local">
          'Frequency of disease'
         </a>
         above.)
        </p>
        <p>
         The geographic distribution of skin test reactivity to MAC is not uniform. A survey of skin test reactivity to a MAC antigen among 275,000 naval recruits who had lived their entire lives in a single county showed skin test reactivity to be most frequent among recruits from the southeastern and gulf coast states (
         <a class="graphic graphic_figure graphicRef56050" href="/z/d/graphic/56050.html" rel="external">
          figure 1
         </a>
         ) [
         <a href="#rid41">
          41
         </a>
         ]. In these areas, more than 70 percent of individuals had been exposed to or infected with MAC or an antigenically similar organism.
        </p>
        <p>
         More recent dual skin test studies have been conducted among healthy individuals in the United States using
         <em>
          M. avium
         </em>
         sensitin, a reagent that has been shown to be both sensitive and specific in distinguishing past disease due to
         <em>
          M. avium
         </em>
         from past disease due to
         <em>
          M. tuberculosis
         </em>
         [
         <a href="#rid42">
          42
         </a>
         ]. Among 784 subjects from the northern and southern US, 40 percent of US-born subjects had
         <em>
          M. avium
         </em>
         -dominant reactions consistent with prior infection with
         <em>
          M. avium
         </em>
         or other NTM;
         <em>
          M. avium
         </em>
         -dominant reactions were found in 46 percent of subjects from southern sites and 33 percent from northern sites. Cross reactions due to NTM were found to be responsible for the majority of
         <a class="drug drug_general" data-topicid="10029" href="/z/d/drug information/10029.html" rel="external">
          tuberculin skin test
         </a>
         reactions in the 5 to 14 mm range [
         <a href="#rid43">
          43
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Pulmonary disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         Since MAC is not a reportable disease, precise prevalence and incidence data are not available.
        </p>
        <p>
         Although rigorous data are lacking, there is widespread impression that the frequency of MAC lung disease may be increasing, as discussed in detail above. (See
         <a class="local">
          'Frequency of disease'
         </a>
         above.)
        </p>
        <p>
         Two major clinical syndromes of MAC lung disease are recognized:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Disease in those with known underlying lung disease, primarily white, middle-aged or older males, often with alcohol abuse and/or smokers with underlying chronic obstructive pulmonary disease. MAC lung disease has also been described in adolescents or adults with cystic fibrosis. (See
         <a class="medical medical_review" href="/z/d/html/5342.html" rel="external">
          "Overview of nontuberculous mycobacterial infections", section on 'Clinical manifestations'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Disease in those without known underlying lung disease, predominantly in nonsmoking women over age 60 years who have nodules and reticular changes on chest radiography. For reasons that are unclear, this is the form of MAC lung disease most likely encountered by clinicians in the US and Canada. (See
         <a class="medical medical_review" href="/z/d/html/5342.html" rel="external">
          "Overview of nontuberculous mycobacterial infections", section on 'Clinical manifestations'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Two other less common forms of MAC lung disease have been described:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A hypersensitivity pneumonitis syndrome most frequently reported in association with hot tub use ("hot tub lung"). (See
         <a class="medical medical_review" href="/z/d/html/5342.html" rel="external">
          "Overview of nontuberculous mycobacterial infections", section on 'Clinical manifestations'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         One report noted an unexpectedly high frequency (78 of 244 patients) of MAC pulmonary infections presenting as solitary pulmonary nodules, which resembled lung cancer [
         <a href="#rid44">
          44
         </a>
         ]. Another smaller study showed similar findings [
         <a href="#rid45">
          45
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5342.html" rel="external">
          "Overview of nontuberculous mycobacterial infections", section on 'Clinical manifestations'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Disseminated disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         Disseminated NTM (particularly MAC) disease primarily occurs in severely immunocompromised patients, such as those with AIDS. It is thought to arise from infection of a mucosal surface (gut or lung), followed by local multiplication and entry into the bloodstream with seeding of other organs and tissues. (See
         <a class="medical medical_review" href="/z/d/html/5345.html" rel="external">
          "Pathogenesis of nontuberculous mycobacterial infections"
         </a>
         .)
        </p>
        <p>
         Prior to the widespread use of potent antiretroviral therapy and mycobacterial antibiotic prophylaxis, disseminated MAC was very common among patients with advanced AIDS in developed countries but rare to nonexistent among patients with advanced AIDS in resource-limited countries where tuberculosis was endemic [
         <a href="#rid46">
          46
         </a>
         ]. This was observed despite studies showing that isolation rates of MAC from the environment and rates of skin test reactivity to MAC in healthy persons were comparable in resource-rich and resource-limited countries [
         <a href="#rid47">
          47,48
         </a>
         ]. This led to the hypothesis that patients in resource-limited countries had relative immunologic protection against MAC conferred by prior BCG and/or latent infection with
         <em>
          M. tuberculosis
         </em>
         [
         <a href="#rid46">
          46
         </a>
         ].
        </p>
        <p>
         The incidence of disseminated MAC has decreased dramatically since the introduction of potent antiretroviral therapy and effective MAC prophylaxis. This is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/3755.html" rel="external">
          "Mycobacterium avium complex (MAC) infections in persons with HIV"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h1">
          MYCOBACTERIUM KANSASII
         </span>
         <span class="headingEndMark">
          —
         </span>
         Because large scale testing of skin test reactivity to
         <em>
          M. kansasii
         </em>
         antigens has not been performed, the geography of
         <em>
          M. kansasii
         </em>
         is less well known than that of MAC. Based upon reports of clinical disease, the organism seems to predominate along the southeastern and southern coastal states and the central plains states [
         <a href="#rid49">
          49
         </a>
         ]. The Centers for Disease Control and Prevention (CDC) surveys noted previously found that
         <em>
          M. kansasii
         </em>
         was the second most common respiratory NTM isolate in state laboratories in the United States, but more recently,
         <em>
          M. abscessus
         </em>
         complex
         <em>
         </em>
         has overtaken
         <em>
          M. kansasii
         </em>
         as the second most common respiratory NTM pathogen [
         <a href="#rid5">
          5,6
         </a>
         ].
        </p>
        <p>
         Unlike other NTM,
         <em>
          M. kansasii
         </em>
         has never been found in soil or natural water supplies but has been recovered consistently from tap water in cities where
         <em>
          M. kansasii
         </em>
         is endemic. Studies in Texas show that
         <em>
          M. kansasii
         </em>
         disease is concentrated in urban areas, supporting a possible association between clinical disease and potable water supplies [
         <a href="#rid50">
          50
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Incidence
         </span>
         <span class="headingEndMark">
          —
         </span>
         The incidence of
         <em>
          M. kansasii
         </em>
         infection was studied in a population-based laboratory survey from 1992 to 1996 in three counties of northern California and was surprisingly, found to be 2.4 cases per 100,000 adults annually [
         <a href="#rid51">
          51
         </a>
         ]. Of the 270 cases identified, 187 were HIV positive, 33 HIV negative, and 50 with HIV status unknown. Patients without HIV tended to be older (median age 61 versus 39) and White (62 versus 49 percent); 40 percent of these patients did not have an identifiable underlying condition. Isolation of
         <em>
          M. kansasii
         </em>
         from respiratory specimens was associated with symptomatic illness in both HIV positive and negative patients. Homelessness and lower socioeconomic status were also important associated findings. The increased frequency reported appeared to track with HIV status (0.75 per 100,000 for HIV negative individuals compared to 115 per 100,000 for HIV positive and 647 per 100,000 for patients with AIDS).
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h2">
          Risk factors
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          M. kansasii
         </em>
         causes pulmonary disease resembling tuberculosis. The major predisposing factor to lung infection is chronic obstructive pulmonary disease (COPD), which is present in over two-thirds of cases; other underlying conditions may include malignancy, immunosuppressive drugs, alcohol abuse, pneumoconiosis, and HIV infection [
         <a href="#rid52">
          52-55
         </a>
         ]. Affected patients tend to be in their fifth decade or older, with an approximate 3:1 male predominance. Certain occupational groups are at increased risk, including miners, welders, sandblasters, and painters [
         <a href="#rid52">
          52
         </a>
         ]. Some patients, however, have no risk factor other than their geographic area of residence.
        </p>
        <p>
         A survey of 56 adults with
         <em>
          M. kansasii
         </em>
         pulmonary infection in Israel diagnosed in the time period 1999 to 2004 noted the following findings [
         <a href="#rid56">
          56
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Mean age 58±18 years
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         64 percent of cases occurred in males
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         59 percent had underlying lung disease
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         15 percent were receiving immunosuppressive medications
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h2">
          HIV-related
         </span>
         <span class="headingEndMark">
          —
         </span>
         In addition to causing pulmonary disease resembling tuberculosis,
         <em>
          M. kansasii
         </em>
         also causes disseminated disease, particularly in HIV-infected individuals. This is discussed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/3705.html" rel="external">
          "Overview of nontuberculous mycobacteria (excluding MAC) in patients with HIV", section on 'Mycobacterium kansasii'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h1">
          RAPIDLY GROWING MYCOBACTERIA
         </span>
         <span class="headingEndMark">
          —
         </span>
         Rapidly growing mycobacteria include three clinically relevant species
         <em>
          M. abscessus
         </em>
         complex,
         <em>
          M. chelonae
         </em>
         , and
         <em>
          M. fortuitum
         </em>
         (
         <a class="graphic graphic_table graphicRef61936" href="/z/d/graphic/61936.html" rel="external">
          table 1
         </a>
         ). The most common of this group of organisms encountered in clinical practice or in the clinical microbiology laboratory is
         <em>
          M. fortuitum
         </em>
         , however, the most important human pathogen is
         <em>
          M abscessus
         </em>
         complex.
         <em>
          M. fortuitum
         </em>
         is rarely a significant respiratory pathogen in the absence of significant aspiration [
         <a href="#rid57">
          57
         </a>
         ].
        </p>
        <p>
         These, and other rapidly growing mycobacterial species, are hardy environmental saprophytes widely distributed in nature and able to withstand extremes of temperature and nutritionally-spartan environments. They have been isolated from soil, dust, water, terrestrial and aquatic animals, hospital environments (including hospital tap water), and contaminated reagents and pharmaceuticals [
         <a href="#rid26">
          26,49,58
         </a>
         ]. An example of nosocomial transmission involves an outbreak of surgical wound infections caused by a novel species of rapidly growing mycobacteria involving 15 females who underwent breast implant insertion at a single medical center [
         <a href="#rid59">
          59
         </a>
         ]. A single surgeon who performed all the surgical operations was identified as the source for the organism.
        </p>
        <p>
         Direct or indirect person-to-person transmission of certain strains of
         <em>
          M. abscessus
         </em>
         has also been suggested. In a study of 168 separate isolates from 30 cystic fibrosis patients infected with
         <em>
          M. abscessus
         </em>
         complex, whole-genome sequencing demonstrated two clusters of drug resistant
         <em>
          M. massiliense
         </em>
         , in which isolates from different patients were highly related to each other, and epidemiological investigation suggested cross-infection between patients within the hospital [
         <a href="#rid60">
          60
         </a>
         ]. Similar clustering across patients was not seen with
         <em>
          M. abscessus
         </em>
         complex isolates.
        </p>
        <p>
         The clinical manifestations, diagnosis, and management of disease caused by rapidly growing mycobacteria are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/5347.html" rel="external">
          "Rapidly growing mycobacterial infections: Mycobacteria abscessus, chelonae, and fortuitum"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h1">
          OTHER NONTUBERCULOUS MYCOBACTERIA
         </span>
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h2">
          Mycobacterium marinum
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although infection with
         <em>
          M. marinum
         </em>
         is uncommon, the epidemiology of
         <em>
          M. marinum
         </em>
         disease is distinctive from the species described above. The natural habitat of
         <em>
          M. marinum
         </em>
         is aquatic, as the name suggests. It is found in fresh and salt water, including marine organisms, swimming pools, and fish tanks.
        </p>
        <p>
         <em>
          M. marinum
         </em>
         causes cutaneous disease as a consequence of exposure to water, usually in the context of a minor abrasion, laceration, puncture wound, or bite wound. Skin infections can occur from putting one's hand into a contaminated fish tank, resulting in the condition called fish tank granuloma [
         <a href="#rid61">
          61
         </a>
         ]. In a series of 63 cases from France, 84 percent were linked to fish tank exposure [
         <a href="#rid62">
          62
         </a>
         ]. A similar epidemiologic pattern has been found in the United States, along with the recognition that
         <em>
          M. marinum
         </em>
         may cause a positive
         <a class="drug drug_general" data-topicid="10029" href="/z/d/drug information/10029.html" rel="external">
          tuberculin skin test
         </a>
         [
         <a href="#rid63">
          63
         </a>
         ].
        </p>
        <p>
         A 50-year epidemic of chronic progressive skin disease among residents of Satowan, in the Federated States of Micronesia, began after World War II [
         <a href="#rid64">
          64
         </a>
         ]. In a case-control study, risk factors for disease were taro farming, which is done in standing water that reaches ankle height, and contact with water-filled World War II-era bomb craters. Histopathology of nine skin lesions demonstrated suppurative granulomatous inflammation and nontuberculous mycobacteria DNA was detected by polymerase chain reaction in seven of nine specimens. The two samples that were able to be sequenced had 95 and 87 percent identity to
         <em>
          M. marinum
         </em>
         .
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h2">
          Mycobacterium xenopi
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          M. xenopi
         </em>
         is a slow-growing nontuberculous mycobacterium that is an opportunistic and nosocomial pathogen. It is an uncommon pathogen that most frequently causes pulmonary infection.
        </p>
        <p>
         Its survival in water systems and resistance to common disinfectants enable
         <em>
          M. xenopi
         </em>
         to contaminate laboratory samples and medical devices such as bronchoscopes, thus causing healthcare-acquired pseudoinfections and laboratory contamination. In a retrospective review of 136 cases of
         <em>
          M. xenopi
         </em>
         infection seen over a 20 year period in France, three types of pulmonary disease were observed that varied with the host: acute infiltrates in immunocompromised hosts, solitary nodular disease in immunocompetent hosts, and cavitary disease in patients with preexisting lung disease [
         <a href="#rid65">
          65
         </a>
         ]. A report from the Netherlands suggests a predominance of
         <em>
          M. xenopi
         </em>
         infections in males with preexisting lung disease [
         <a href="#rid66">
          66
         </a>
         ]. A study from Great Britain suggests an unusually high mortality rate in such patients for unclear reasons [
         <a href="#rid67">
          67
         </a>
         ].
        </p>
        <p>
         The most common extrapulmonary sites are bone and joints. Fifty-eight cases of nosocomial spinal infection occurred in healthy patients following percutaneous nucleotomy for lower back pain or sciatica [
         <a href="#rid68">
          68,69
         </a>
         ]. The outbreak stemmed from the practice of rinsing the surgical instruments with tap water. There were also seven cases of
         <em>
          M. xenopi
         </em>
         arthritis following invasive surgical procedures [
         <a href="#rid70">
          70
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H376675059">
         <span class="h2">
          Mycobacterium haemophilum
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          M. haemophilum
         </em>
         is slow-growing nontuberculous mycobacterium that is thought to live in water [
         <a href="#rid71">
          71
         </a>
         ]. It has a predilection for causing skin and soft tissue infections, particularly in immunocompromised hosts because it grows at 30°C [
         <a href="#rid72">
          72
         </a>
         ]. It is the second most common cause of cervical lymphadenitis in children [
         <a href="#rid73">
          73
         </a>
         ], and has been reported rarely to cause lymphadenitis in immunocompetent adults [
         <a href="#rid74">
          74
         </a>
         ].
        </p>
        <p>
         <em>
          M. haemophilum
         </em>
         was identified as the cause of an outbreak of skin and soft tissue infection and cervical lymphadenitis in 12 immunocompetent individuals, which occurred in the setting of application of permanent makeup to the eyebrows performed by a single makeup artist in Switzerland [
         <a href="#rid75">
          75
         </a>
         ].
        </p>
        <p>
         <em>
          M. haemophilum
         </em>
         is difficult to isolate because it requires special media and conditions (incubation at 30°C) for growth. (See
         <a class="medical medical_review" href="/z/d/html/5343.html" rel="external">
          "Microbiology of nontuberculous mycobacteria", section on 'Infrequent or difficult to culture NTM'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h2">
          Mycobacterium simiae
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          M. simiae
         </em>
         has been isolated in the southwestern United States and in other areas of the world such as Israel, Cuba, and western Europe [
         <a href="#rid5">
          5,76
         </a>
         ]. Only a minority of
         <em>
          M. simiae
         </em>
         respiratory isolates obtained from immune competent hosts are clinically relevant, making interpretation of the clinical significance of
         <em>
          M. simiae
         </em>
         isolates difficult [
         <a href="#rid76">
          76
         </a>
         ]. Interpreting the clinical significance of
         <em>
          M. simiae
         </em>
         isolates is especially important due to the extreme difficulty effectively treating true
         <em>
          M. simiae
         </em>
         lung disease.
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h2">
          Mycobacterium szulgai
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          M. szulgai
         </em>
         has been recovered from environmental sources and isolation is usually associated with preexisting pulmonary conditions such as chronic obstructive lung disease or healed tuberculosis [
         <a href="#rid77">
          77
         </a>
         ]. The isolation of
         <em>
          M. szulgai
         </em>
         is also usually associated with significant disease.
        </p>
        <p class="headingAnchor" id="H213738097">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Mycobacteria other than
         <em>
          Mycobacterium tuberculosis
         </em>
         and
         <em>
          Mycobacterium leprae
         </em>
         are generally free-living organisms that are ubiquitous in the environment (
         <a class="graphic graphic_table graphicRef61936" href="/z/d/graphic/61936.html" rel="external">
          table 1
         </a>
         ). They have been recovered from surface water, tap water, soil, domestic and wild animals, milk, and food products. These organisms can also inhabit body surfaces or secretions without causing disease. (See
         <a class="local">
          'Introduction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The most common nontuberculous species causing human disease in the United States are the slowly growing species of the
         <em>
          M. avium
         </em>
         complex (MAC) and
         <em>
          M. kansasii
         </em>
         and the rapidly growing
         <em>
          M. abscessus
         </em>
         complex. Less common human pathogens include the slowly growing species
         <em>
          M. marinum
         </em>
         ,
         <em>
          M. xenopi
         </em>
         ,
         <em>
          M. simiae
         </em>
         ,
         <em>
          M. malmoense
         </em>
         , and
         <em>
          M. ulcerans
         </em>
         . (See
         <a class="local">
          'Common pathogenic species'
         </a>
         above and
         <a class="local">
          'Mycobacterium avium complex'
         </a>
         above and
         <a class="local">
          'Mycobacterium kansasii'
         </a>
         above and
         <a class="local">
          'Rapidly growing mycobacteria'
         </a>
         above and
         <a class="local">
          'Other nontuberculous mycobacteria'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Although precise estimates of incidence and prevalence of nontuberculous mycobacterial (NTM) disease are difficult to determine, the burden of NTM disease, particularly lung disease, appears to be increasing worldwide. (See
         <a class="local">
          'Frequency of disease'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         NTM cause four distinct clinical syndromes:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Progressive pulmonary disease (especially in older persons) caused primarily by MAC,
         <em>
          M. abscessus
         </em>
         complex, and
         <em>
          M. kansasii
         </em>
         .
         <em>
          M. fortuitum
         </em>
         and
         <em>
          M. chelonae
         </em>
         rarely causing lung disease.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Superficial lymphadenitis, especially cervical lymphadenitis, in children caused mostly by MAC,
         <em>
          M. scrofulaceum
         </em>
         , and, in northern Europe,
         <em>
          M. malmoense
         </em>
         and
         <em>
          M. haemophilum
         </em>
         ; the most common cause in adults, however, is
         <em>
          M. tuberculosis
         </em>
         .
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Disseminated disease in severely immunocompromised patients (eg, disseminated MAC in patients with AIDS). (See
         <a class="local">
          'Disseminated disease'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Skin and soft tissue infection usually as a consequence of direct inoculation. (See
         <a class="local">
          'Introduction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Unlike other NTM,
         <em>
          M. kansasii
         </em>
         has never been found in soil or natural water supplies but has been recovered consistently from tap water in cities where
         <em>
          M. kansasii
         </em>
         is endemic.
         <em>
          M. kansasii
         </em>
         causes pulmonary disease resembling tuberculosis. The major predisposing factor to lung infection is chronic obstructive pulmonary disease (COPD), which is present in over two-thirds of cases; other underlying conditions may include malignancy, immunosuppressive drugs, alcohol abuse, pneumoconiosis, and HIV infection. (See
         <a class="local">
          'Mycobacterium kansasii'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Rapidly growing mycobacteria include three clinically relevant species:
         <em>
          M. abscessus
         </em>
         ,
         <em>
          M. chelonae
         </em>
         , and
         <em>
          M. fortuitum
         </em>
         (
         <a class="graphic graphic_table graphicRef61936" href="/z/d/graphic/61936.html" rel="external">
          table 1
         </a>
         ). Among these, the most important human pathogen is
         <em>
          M. abscessus
         </em>
         complex. Rapidly growing mycobacterial species are hardy environmental saprophytes widely distributed in nature and able to withstand extremes of temperature and nutritionally spartan environments. (See
         <a class="local">
          'Rapidly growing mycobacteria'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/5347.html" rel="external">
          "Rapidly growing mycobacterial infections: Mycobacteria abscessus, chelonae, and fortuitum"
         </a>
         .)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Wolinsky E, Rynearson TK. Mycobacteria in soil and their relation to disease-associated strains. Am Rev Respir Dis 1968; 97:1032.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chapman JS. The ecology of the atypicalmycobacteria. Arch Environ Health 1971; 22:41.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goslee S, Wolinsky E. Water as a source of potentially pathogenic mycobacteria. Am Rev Respir Dis 1976; 113:287.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gruft H, Falkinham JO 3rd, Parker BC. Recent experience in the epidemiology of disease caused by atypical mycobacteria. Rev Infect Dis 1981; 3:990.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175:367.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Daley CL, Iaccarino JM, Lange C, et al. Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline. Clin Infect Dis 2020; 71:e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lincoln EM, Gilbert LA. Disease in children due to mycobacteria other than Mycobacterium tuberculosis. Am Rev Respir Dis 1972; 105:683.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vesterhus P, Holland SM, Abrahamsen TG, Bjerknes R. Familial disseminated infection due to atypical mycobacteria with childhood onset. Clin Infect Dis 1998; 27:822.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Herlin T, Thelle T, Kragballe K, et al. Sustained depression of monocyte cytotoxicity in a boy with disseminated nontuberculous mycobacteriosis. J Pediatr 1981; 99:264.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Winthrop KL, McNelley E, Kendall B, et al. Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. Am J Respir Crit Care Med 2010; 182:977.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Winthrop KL, Baxter R, Liu L, et al. The reliability of diagnostic coding and laboratory data to identify tuberculosis and nontuberculous mycobacterial disease among rheumatoid arthritis patients using anti-tumor necrosis factor therapy. Pharmacoepidemiol Drug Saf 2011; 20:229.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Griffith DE, Aksamit TR. Managing Mycobacterium avium Complex Lung Disease With a Little Help From My Friend. Chest 2021; 159:1372.
          </a>
         </li>
         <li class="breakAll">
          Wagner D, Lipman M, Cooray S, et al. Nontuberculous Mycobacterial Disease: A Comprehensive Approach to Diagnosis and Management, Griffith DE (Ed), Humana Press, Switzerland 2019.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Izumi K, Morimoto K, Hasegawa N, et al. Epidemiology of Adults and Children Treated for Nontuberculous Mycobacterial Pulmonary Disease in Japan. Ann Am Thorac Soc 2019; 16:341.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schildkraut JA, Gallagher J, Morimoto K, et al. Epidemiology of nontuberculous mycobacterial pulmonary disease in Europe and Japan by Delphi estimation. Respir Med 2020; 173:106164.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee H, Myung W, Koh WJ, et al. Epidemiology of Nontuberculous Mycobacterial Infection, South Korea, 2007-2016. Emerg Infect Dis 2019; 25:569.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Al-Houqani M, Jamieson F, Mehta M, et al. Aging, COPD, and other risk factors do not explain the increased prevalence of pulmonary Mycobacterium avium complex in Ontario. Chest 2012; 141:190.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thomson RM, NTM working group at Queensland TB Control Centre and Queensland Mycobacterial Reference Laboratory. Changing epidemiology of pulmonary nontuberculous mycobacteria infections. Emerg Infect Dis 2010; 16:1576.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Winthrop KL, Marras TK, Adjemian J, et al. Incidence and Prevalence of Nontuberculous Mycobacterial Lung Disease in a Large U.S. Managed Care Health Plan, 2008-2015. Ann Am Thorac Soc 2020; 17:178.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Prevots DR, Shaw PA, Strickland D, et al. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med 2010; 182:970.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Adjemian J, Olivier KN, Seitz AE, et al. Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries. Am J Respir Crit Care Med 2012; 185:881.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Henkle E, Hedberg K, Schafer S, et al. Population-based Incidence of Pulmonary Nontuberculous Mycobacterial Disease in Oregon 2007 to 2012. Ann Am Thorac Soc 2015; 12:642.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Adjemian J, Olivier KN, Prevots DR. Epidemiology of Pulmonary Nontuberculous Mycobacterial Sputum Positivity in Patients with Cystic Fibrosis in the United States, 2010-2014. Ann Am Thorac Soc 2018; 15:817.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Katila ML, Brander E, Backman A. Neonatal BCG vaccination and mycobacterial cervical adenitis in childhood. Tubercle 1987; 68:291.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Romanus V, Hallander HO, Wåhlén P, et al. Atypical mycobacteria in extrapulmonary disease among children. Incidence in Sweden from 1969 to 1990, related to changing BCG-vaccination coverage. Tuber Lung Dis 1995; 76:300.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wolinsky E. Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis 1979; 119:107.
          </a>
         </li>
         <li class="breakAll">
          Horsburgh RC Jr. Epidemiology of Mycobacterium avium complex. In: Mycobacterium Avium Complex Infection, Korvick JA, Benson CA (Eds), Marcel Dekker, Inc, New York 1996. p.1.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meissner G, Anz W. Sources of Mycobacterium avium complex infection resulting in human diseases. Am Rev Respir Dis 1977; 116:1057.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meissner PS, Falkinham JO 3rd. Plasmid DNA profiles as epidemiological markers for clinical and environmental isolates of Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium scrofulaceum. J Infect Dis 1986; 153:325.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           von Reyn CF, Maslow JN, Barber TW, et al. Persistent colonisation of potable water as a source of Mycobacterium avium infection in AIDS. Lancet 1994; 343:1137.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           du Moulin GC, Stottmeier KD, Pelletier PA, et al. Concentration of Mycobacterium avium by hospital hot water systems. JAMA 1988; 260:1599.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marras TK, Wallace RJ Jr, Koth LL, et al. Hypersensitivity pneumonitis reaction to Mycobacterium avium in household water. Chest 2005; 127:664.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reed C, von Reyn CF, Chamblee S, et al. Environmental risk factors for infection with Mycobacterium avium complex. Am J Epidemiol 2006; 164:32.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Feazel LM, Baumgartner LK, Peterson KL, et al. Opportunistic pathogens enriched in showerhead biofilms. Proc Natl Acad Sci U S A 2009; 106:16393.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gebert MJ, Delgado-Baquerizo M, Oliverio AM, et al. Ecological Analyses of Mycobacteria in Showerhead Biofilms and Their Relevance to Human Health. mBio 2018; 9.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Edwards LB. Community-wide tuberculin testing study in Pamlico county, North Carolina. Am Rev Respir Dis 1965; 92:43.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lind A, Larsson LO, Bentzon MW, et al. Sensitivity to sensitins and tuberculin in Swedish children. I. A study of schoolchildren in an urban area. Tubercle 1991; 72:29.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Osman AA, Hakim JG, Lüneborg-Nielsen M, et al. Comparative skin testing with PPD tuberculin, Mycobacterium avium and M. scrofulaceum sensitin in schoolchildren in Saudi Arabia. Tuber Lung Dis 1994; 75:38.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khan K, Wang J, Marras TK. Nontuberculous mycobacterial sensitization in the United States: national trends over three decades. Am J Respir Crit Care Med 2007; 176:306.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marras TK, Chedore P, Ying AM, Jamieson F. Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997 2003. Thorax 2007; 62:661.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Edwards LB, Acquaviva FA, Livesay VT, et al. An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. Am Rev Respir Dis 1969; 99:Suppl:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           von Reyn CF, Williams DE, Horsburgh CR Jr, et al. Dual skin testing with Mycobacterium avium sensitin and purified protein derivative to discriminate pulmonary disease due to M. avium complex from pulmonary disease due to Mycobacterium tuberculosis. J Infect Dis 1998; 177:730.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           von Reyn CF, Horsburgh CR, Olivier KN, et al. Skin test reactions to Mycobacterium tuberculosis purified protein derivative and Mycobacterium avium sensitin among health care workers and medical students in the United States. Int J Tuberc Lung Dis 2001; 5:1122.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Teirstein AS, Damsker B, Kirschner PA, et al. Pulmonary infection with Mycobacterium avium-intracellulare: diagnosis, clinical patterns, treatment. Mt Sinai J Med 1990; 57:209.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lim J, Lyu J, Choi CM, et al. Non-tuberculous mycobacterial diseases presenting as solitary pulmonary nodules. Int J Tuberc Lung Dis 2010; 14:1635.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fordham von Reyn C, Arbeit RD, Tosteson AN, et al. The international epidemiology of disseminated Mycobacterium avium complex infection in AIDS. International MAC Study Group. AIDS 1996; 10:1025.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           von Reyn CF, Waddell RD, Eaton T, et al. Isolation of Mycobacterium avium complex from water in the United States, Finland, Zaire, and Kenya. J Clin Microbiol 1993; 31:3227.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           von Reyn CF, Barber TW, Arbeit RD, et al. Evidence of previous infection with Mycobacterium avium-Mycobacterium intracellulare complex among healthy subjects: an international study of dominant mycobacterial skin test reactions. J Infect Dis 1993; 168:1553.
          </a>
         </li>
         <li class="breakAll">
          Chapman J. The Atypical Mycobacteria, Plenum Publishing, New York 1977.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Steadham JE. High-catalase strains of Mycobacterium kansasii isolated from water in Texas. J Clin Microbiol 1980; 11:496.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bloch KC, Zwerling L, Pletcher MJ, et al. Incidence and clinical implications of isolation of Mycobacterium kansasii: results of a 5-year, population-based study. Ann Intern Med 1998; 129:698.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marks J. "Opportunist" mycobacteria in England and Wales. Tubercle 1969; 50:Suppl:78.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Johanson WG Jr, Nicholson DP. Pulmonary disease due to Mycobacterium Kansasii. An analysis of some factors affecting prognosis. Am Rev Respir Dis 1969; 99:73.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lillo M, Orengo S, Cernoch P, Harris RL. Pulmonary and disseminated infection due to Mycobacterium kansasii: a decade of experience. Rev Infect Dis 1990; 12:760.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bamberger DM, Driks MR, Gupta MR, et al. Mycobacterium kansasii among patients infected with human immunodeficiency virus in Kansas City. Kansas City AIDS Research Consortium. Clin Infect Dis 1994; 18:395.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shitrit D, Baum GL, Priess R, et al. Pulmonary Mycobacterium kansasii infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome. Chest 2006; 129:771.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Park S, Suh GY, Chung MP, et al. Clinical significance of Mycobacterium fortuitum isolated from respiratory specimens. Respir Med 2008; 102:437.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baker AW, Lewis SS, Alexander BD, et al. Two-Phase Hospital-Associated Outbreak of Mycobacterium abscessus: Investigation and Mitigation. Clin Infect Dis 2017; 64:902.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rahav G, Pitlik S, Amitai Z, et al. An outbreak of Mycobacterium jacuzzii infection following insertion of breast implants. Clin Infect Dis 2006; 43:823.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bryant JM, Grogono DM, Greaves D, et al. Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study. Lancet 2013; 381:1551.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wayne LG, Sramek HA. Agents of newly recognized or infrequently encountered mycobacterial diseases. Clin Microbiol Rev 1992; 5:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aubry A, Chosidow O, Caumes E, et al. Sixty-three cases of Mycobacterium marinum infection: clinical features, treatment, and antibiotic susceptibility of causative isolates. Arch Intern Med 2002; 162:1746.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lewis FM, Marsh BJ, von Reyn CF. Fish tank exposure and cutaneous infections due to Mycobacterium marinum: tuberculin skin testing, treatment, and prevention. Clin Infect Dis 2003; 37:390.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lillis JV, Ansdell VE, Ruben K, et al. Sequelae of World War II: an outbreak of chronic cutaneous nontuberculous mycobacterial infection among Satowanese islanders. Clin Infect Dis 2009; 48:1541.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Andréjak C, Lescure FX, Pukenyte E, et al. Mycobacterium xenopi pulmonary infections: a multicentric retrospective study of 136 cases in north-east France. Thorax 2009; 64:291.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Ingen J, Boeree MJ, de Lange WC, et al. Mycobacterium xenopi clinical relevance and determinants, the Netherlands. Emerg Infect Dis 2008; 14:385.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jenkins PA, Campbell IA, Research Committee of The British Thoracic Society. Pulmonary disease caused by Mycobacterium xenopi in HIV-negative patients: five year follow-up of patients receiving standardised treatment. Respir Med 2003; 97:439.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Astagneau P, Desplaces N, Vincent V, et al. Mycobacterium xenopi spinal infections after discovertebral surgery: investigation and screening of a large outbreak. Lancet 2001; 358:747.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ziza JM. [Lessons in medicine: apropos of a modern epidemic of Mycobacterium xenopi spondylodiscitis]. Rev Med Interne 1997; 18:845.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Salliot C, Desplaces N, Boisrenoult P, et al. Arthritis due to Mycobacterium xenopi: a retrospective study of 7 cases in France. Clin Infect Dis 2006; 43:987.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Falkinham JO 3rd, Norton CD, LeChevallier MW. Factors influencing numbers of Mycobacterium avium, Mycobacterium intracellulare, and other Mycobacteria in drinking water distribution systems. Appl Environ Microbiol 2001; 67:1225.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Saubolle MA, Kiehn TE, White MH, et al. Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans. Clin Microbiol Rev 1996; 9:435.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cohen YH, Amir J, Ashkenazi S, et al. Mycobacterium haemophilum and lymphadenitis in immunocompetent children, Israel. Emerg Infect Dis 2008; 14:1437.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Minani TJ, Saubolle MA, Yu E, Sussland Z. Mycobacterium haemophilum as a novel etiology of cervical lymphadenitis in an otherwise healthy adult patient. J Clin Microbiol 2010; 48:2636.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Giulieri S, Morisod B, Edney T, et al. Outbreak of Mycobacterium haemophilum infections after permanent makeup of the eyebrows. Clin Infect Dis 2011; 52:488.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Ingen J, Boeree MJ, Dekhuijzen PN, van Soolingen D. Clinical relevance of Mycobacterium simiae in pulmonary samples. Eur Respir J 2008; 31:106.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Ingen J, Boeree MJ, de Lange WC, et al. Clinical relevance of Mycobacterium szulgai in The Netherlands. Clin Infect Dis 2008; 46:1200.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 5344 Version 22.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4870217" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Mycobacteria in soil and their relation to disease-associated strains.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4991961" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : The ecology of the atypicalmycobacteria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1259237" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Water as a source of potentially pathogenic mycobacteria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7339831" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Recent experience in the epidemiology of disease caused by atypical mycobacteria.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17277290" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32628747" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4623179" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Disease in children due to mycobacteria other than Mycobacterium tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9798040" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Familial disseminated infection due to atypical mycobacteria with childhood onset.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7252689" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Sustained depression of monocyte cytotoxicity in a boy with disseminated nontuberculous mycobacteriosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20508209" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21351303" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : The reliability of diagnostic coding and laboratory data to identify tuberculosis and nontuberculous mycobacterial disease among rheumatoid arthritis patients using anti-tumor necrosis factor therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33080299" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Managing Mycobacterium avium Complex Lung Disease With a Little Help From My Friend.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33080299" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Managing Mycobacterium avium Complex Lung Disease With a Little Help From My Friend.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30339468" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Epidemiology of Adults and Children Treated for Nontuberculous Mycobacterial Pulmonary Disease in Japan.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32992265" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Epidemiology of nontuberculous mycobacterial pulmonary disease in Europe and Japan by Delphi estimation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30789139" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Epidemiology of Nontuberculous Mycobacterial Infection, South Korea, 2007-2016.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21724552" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Aging, COPD, and other risk factors do not explain the increased prevalence of pulmonary Mycobacterium avium complex in Ontario.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20875283" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Changing epidemiology of pulmonary nontuberculous mycobacteria infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31830805" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Incidence and Prevalence of Nontuberculous Mycobacterial Lung Disease in a Large U.S. Managed Care Health Plan, 2008-2015.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20538958" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22312016" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25692495" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Population-based Incidence of Pulmonary Nontuberculous Mycobacterial Disease in Oregon 2007 to 2012.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29897781" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Epidemiology of Pulmonary Nontuberculous Mycobacterial Sputum Positivity in Patients with Cystic Fibrosis in the United States, 2010-2014.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3138802" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Neonatal BCG vaccination and mycobacterial cervical adenitis in childhood.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7579311" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Atypical mycobacteria in extrapulmonary disease among children. Incidence in Sweden from 1969 to 1990, related to changing BCG-vaccination coverage.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/369415" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Nontuberculous mycobacteria and associated diseases
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/369415" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Nontuberculous mycobacteria and associated diseases
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/931182" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Sources of Mycobacterium avium complex infection resulting in human diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3944484" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Plasmid DNA profiles as epidemiological markers for clinical and environmental isolates of Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium scrofulaceum.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7910236" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Persistent colonisation of potable water as a source of Mycobacterium avium infection in AIDS.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3411741" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Concentration of Mycobacterium avium by hospital hot water systems.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15706013" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Hypersensitivity pneumonitis reaction to Mycobacterium avium in household water.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16675537" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Environmental risk factors for infection with Mycobacterium avium complex.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19805310" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Opportunistic pathogens enriched in showerhead biofilms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30377276" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Ecological Analyses of Mycobacteria in Showerhead Biofilms and Their Relevance to Human Health.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Community-wide tuberculin testing study in Pamlico county, North Carolina
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1882443" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Sensitivity to sensitins and tuberculin in Swedish children. I. A study of schoolchildren in an urban area.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8161763" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Comparative skin testing with PPD tuberculin, Mycobacterium avium and M. scrofulaceum sensitin in schoolchildren in Saudi Arabia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17507546" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Nontuberculous mycobacterial sensitization in the United States: national trends over three decades.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17311842" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997 2003.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5767603" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9498455" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Dual skin testing with Mycobacterium avium sensitin and purified protein derivative to discriminate pulmonary disease due to M. avium complex from pulmonary disease due to Mycobacterium tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11769770" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Skin test reactions to Mycobacterium tuberculosis purified protein derivative and Mycobacterium avium sensitin among health care workers and medical students in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2247097" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Pulmonary infection with Mycobacterium avium-intracellulare: diagnosis, clinical patterns, treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21144251" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Non-tuberculous mycobacterial diseases presenting as solitary pulmonary nodules.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8853737" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : The international epidemiology of disseminated Mycobacterium avium complex infection in AIDS. International MAC Study Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8308115" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Isolation of Mycobacterium avium complex from water in the United States, Finland, Zaire, and Kenya.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8245545" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Evidence of previous infection with Mycobacterium avium-Mycobacterium intracellulare complex among healthy subjects: an international study of dominant mycobacterial skin test reactions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8245545" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Evidence of previous infection with Mycobacterium avium-Mycobacterium intracellulare complex among healthy subjects: an international study of dominant mycobacterial skin test reactions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7381016" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : High-catalase strains of Mycobacterium kansasii isolated from water in Texas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9841601" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Incidence and clinical implications of isolation of Mycobacterium kansasii: results of a 5-year, population-based study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5407742" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : "Opportunist" mycobacteria in England and Wales.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5762115" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Pulmonary disease due to Mycobacterium Kansasii. An analysis of some factors affecting prognosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2237115" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Pulmonary and disseminated infection due to Mycobacterium kansasii: a decade of experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8011822" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Mycobacterium kansasii among patients infected with human immunodeficiency virus in Kansas City. Kansas City AIDS Research Consortium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16537880" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Pulmonary Mycobacterium kansasii infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17997087" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Clinical significance of Mycobacterium fortuitum isolated from respiratory specimens.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28077517" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Two-Phase Hospital-Associated Outbreak of Mycobacterium abscessus: Investigation and Mitigation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16941361" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : An outbreak of Mycobacterium jacuzzii infection following insertion of breast implants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23541540" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1735092" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Agents of newly recognized or infrequently encountered mycobacterial diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12153378" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Sixty-three cases of Mycobacterium marinum infection: clinical features, treatment, and antibiotic susceptibility of causative isolates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12884164" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Fish tank exposure and cutaneous infections due to Mycobacterium marinum: tuberculin skin testing, treatment, and prevention.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19405866" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Sequelae of World War II: an outbreak of chronic cutaneous nontuberculous mycobacterial infection among Satowanese islanders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19052044" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Mycobacterium xenopi pulmonary infections: a multicentric retrospective study of 136 cases in north-east France.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18325251" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Mycobacterium xenopi clinical relevance and determinants, the Netherlands.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12693807" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Pulmonary disease caused by Mycobacterium xenopi in HIV-negative patients: five year follow-up of patients receiving standardised treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11551599" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Mycobacterium xenopi spinal infections after discovertebral surgery: investigation and screening of a large outbreak.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9499984" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : [Lessons in medicine: apropos of a modern epidemic of Mycobacterium xenopi spondylodiscitis].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16983609" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Arthritis due to Mycobacterium xenopi: a retrospective study of 7 cases in France.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11229914" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Factors influencing numbers of Mycobacterium avium, Mycobacterium intracellulare, and other Mycobacteria in drinking water distribution systems.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8894345" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18760014" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Mycobacterium haemophilum and lymphadenitis in immunocompetent children, Israel.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20484607" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Mycobacterium haemophilum as a novel etiology of cervical lymphadenitis in an otherwise healthy adult patient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21258102" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Outbreak of Mycobacterium haemophilum infections after permanent makeup of the eyebrows.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18166593" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Clinical relevance of Mycobacterium simiae in pulmonary samples.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18444856" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Clinical relevance of Mycobacterium szulgai in The Netherlands.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
